Combined Peri-operative Lapatinib and Trastuzumab in Early HER2 Positive Breast Cancer can Identify Early Responders: Results from the UK EPHOS-B Trial (CRUK/08/002

Thumbnail Image

Files

Supplementary material for EPHOS - 20212.pdf (436.64 KB)
EPHOS-B manuscript 20211221 for CCR accepted for publication (1).pdf (776.92 KB)

Embargo End Date

ICR Authors

Bliss, Judith
 Porta, Nuria
 Emson, Marie

Authors

Bliss, J
Porta, N
Emson, M
Miller, S
Morden, J

Document Type

Journal Article

Date

2022-04-01

Date Accepted

2021-12-20

Abstract

Citation

Clinical Cancer Research

DOI

URI

https://repository.icr.ac.uk/handle/internal/4965

Rights

http://www.rioxx.net/licenses/all-rights-reserved

Source Title

Publisher

American Association for Cancer Research

ISSN

1078-0432

eISSN

Collections

Clinical Studies

Research Team

Clinical Trials & Statistics Unit

Notes